Clinical Trial Detail

NCT ID NCT04116437
Title A Study of Zanubrutinib (BGB-3111) in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Intolerant of Prior Treatment With Ibrutinib
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors BeiGene
Indications

CLL/SLL

chronic lymphocytic leukemia

Therapies

Zanubrutinib

Age Groups: adult senior

No variant requirements are available.